This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Bayer Pharmaceuticals Corporation. Active years: 2003-2005.
Company Filing History:
Years Active: 2003-2005
Title: The Innovations of Rudiger Heidemann
Introduction
Rudiger Heidemann is an accomplished inventor based in Emeryville, CA. He has made significant contributions to the field of biotechnology, particularly in the area of mammalian cell culture. With a total of 2 patents, Heidemann's work focuses on improving methods for cell expansion and storage.
Latest Patents
Heidemann's latest patents include a "Device and method for seed-train expansion of mammalian cells." This invention describes a dedicated inoculation bioreactor designed to enhance the growth of mammalian cells prior to their transfer to a production bioreactor. The bioreactor features an 'inoculation well' that allows for optimal cell growth by monitoring and adjusting the media conditions.
Another notable patent is the "Cryopreservation bag assembly for mammalian cell lines." This innovative bag assembly is constructed from polytetrafluoroethylene fabric and is designed to hold sufficient cells for direct inoculation into a bioreactor. The design minimizes contamination risks and allows for efficient filling and sealing processes.
Career Highlights
Rudiger Heidemann is currently employed at Bayer Pharmaceuticals Corporation, where he continues to advance his research in biotechnology. His work has been instrumental in developing methods that enhance the efficiency of mammalian cell culture, which is crucial for protein production.
Collaborations
Heidemann collaborates with notable colleagues such as Mokhtar Mered and De Qian Wang. Their combined expertise contributes to the innovative projects at Bayer Pharmaceuticals Corporation.
Conclusion
Rudiger Heidemann's contributions to biotechnology through his patents and work at Bayer Pharmaceuticals Corporation highlight his role as a leading inventor in the field. His innovations in mammalian cell culture are paving the way for advancements in protein production and biopharmaceuticals.
